Keywords: ADHA drgs, Market forecasts, GlobalData, Shire, Daytrana, Vyvanse, Intuniv
Global ADHD market set to grow at a CAGR of 8% to 2018
Article | 14 December 2011
The global attention deficit hyperactivity disorder (ADHD) therapeutics market was valued at $3.86 billion in 2010, according to a new report from ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Neovacs moving forward in rheumatoid arthritis, say analysts
